🔗 Visit the ClinicalTrials.gov page for NCT01497392
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Cholangiocarcinoma: molecular pathways and therapeutic opportunities. | Semin Liver Dis | 2014 | 1.28 |
| 2 | Targeting the tumour microenvironment in ovarian cancer. | Eur J Cancer | 2016 | 0.86 |
| 3 | Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models. | Br J Cancer | 2013 | 0.83 |
| 4 | Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment. | J Cancer | 2016 | 0.83 |
| 5 | Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians. | World J Clin Oncol | 2016 | 0.80 |
| 6 | State of the art biological therapies in pancreatic cancer. | World J Gastrointest Oncol | 2016 | 0.78 |
| 7 | Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design. | Cancer Metastasis Rev | 2016 | 0.76 |
| 8 | Pancreatic cancer from bench to bedside: molecular pathways and treatment options. | Ann Transl Med | 2016 | 0.75 |